Perceived differences between intensivists and infectious diseases consultants facing antimicrobial resistance: a
Jordi Rello1,2, Vandana Kalwaje Eshwara3, Andrew Conway-Morris4
1CIBER de Enfermedades Respiratorias, CIBERES, Barcelona, Spain. jrello@crips.es.
Abstract:
To identify differences in perception on multi-drug-resistant (MDR) organisms and their management at intensive care units (ICU). A cross-sectional survey was conducted. A proposal addressing a pathogen priority list (PPL) for ICU, arising from the TOTEM study, was compared with a sample of global experts in infections in critically ill patients. The survey was responded by 129 experts. Globally, ESBL Enterobacteriaceae, followed by carbapenem-resistant Acinetobacter baumannii and carbapenem-resistant Klebsiella pneumoniae, were the main concerns. Some differences in opinion were identified between 63 (49%) ICU physicians (ICU/anesthesiology) and 43 (33%) infectious disease consultants (ID physicians/microbiologists). The pathogens most concerning in the ICU for intensivists were ESBL Enterobacteriaceae (38%) versus carbapenem-resistant A. baumannii (48.3%) for ID consultants, (p < 0.05). Increasing number of ID consultants over intensivists (26% vs 14%) reported difficulty in choosing initial therapy for carbapenem-resistant A. baumannii. For intensivists, the urgent measures to limit development of antibiotic resistance were headed by cohort measures (26.3%) versus increasing nurse/patient ratio (32.5%) for ID consultants, (p < 0.05). Regarding effectiveness to prevent MDR development and spread, education programs (42.4%) were the priority for intensivists versus external consultation (35.7%) for ID consultants. Finally, both groups agreed that carbapenem resistance was the most pressing concern (> 70%) regarding emerging resistance. Differences in priorities regarding organisms, infection control practices, and educational priorities were visualized between ID/clinical microbiologists and ICU/anesthesiologists. Multi-disciplinary collaboration is required to achieve best care for ICU patients with severe infections.
Insights
Intensivists and infectious disease experts differ on managing multi-drug-resistant organisms in ICUs. Carbapenem resistance is a top concern for both, but priorities for control and education vary, highlighting the need for collaboration.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Microbiology
Background:
- Multi-drug-resistant (MDR) organisms pose a significant threat in intensive care units (ICUs).
- Understanding expert perceptions on MDR organisms and their management is crucial for effective control strategies.
Purpose of the Study:
- To identify and compare the perceptions of intensive care unit (ICU) physicians and infectious disease (ID) consultants regarding MDR organisms and their management.
- To highlight differences in pathogen priorities, treatment challenges, and infection control strategies between these expert groups.
Main Methods:
- A cross-sectional survey was conducted among 129 global experts in infections in critically ill patients.
- Respondents included ICU physicians (ICU/anesthesiology) and ID physicians/microbiologists.
- Survey data were analyzed to identify differences in opinions on MDR organisms, management, and control.
Main Results:
- Globally, ESBL Enterobacteriaceae, carbapenem-resistant *Acinetobacter baumannii*, and carbapenem-resistant *Klebsiella pneumoniae* were major concerns.
- Significant differences were observed between ICU physicians and ID consultants regarding pathogen priorities and challenges in initial therapy selection.
- Priorities for urgent measures to limit antibiotic resistance and prevent MDR spread also differed between the two groups, with carbapenem resistance being a universal concern.
Conclusions:
- Perceptions and priorities regarding MDR organisms, infection control, and education vary between ICU physicians and ID/clinical microbiologists.
- Addressing these differences through multi-disciplinary collaboration is essential for optimizing the care of critically ill patients with severe infections.
- Carbapenem resistance is recognized as the most pressing emerging resistance concern by both specialties.
More Related Videos
09:59Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance
Published on: July 21, 2023
03:22Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
Related Concept Videos
Cross-Sectional Research
Types of Global Positioning System Surveys
Surveys
Profile Leveling and Cross Sections
Spinal Cord: Cross-sectional Anatomy
Gray Matter and its Components
Central to the gray matter is...
Introduction to Surveying, Plane Surveying and Geodetic Surveys
